While long-term administration for 4 and 6 weeks, particularly at high doses (6 and 12 mg/kg/day), resulted in primary hypothyroidism (reduced serum T3 and T4 levels and elevated serum TSH levels as well as altered Dio1 and Dio3 expression level). The gene discussed is DIO1; the disease is Primary hypothyroidism.